No profile data available.
Tonix Pharmaceuticals Holding Corp. (TNXP) is a healthcare company in the brain and nerve treatment drugs industry, based in Berkeley Heights, United States, with about 142 full-time employees.
In Q3 2025 (the quarter ended September 30, 2025) revenue was $3.29 million. Its market capitalization was $125.20 million as of October 9, 2026.
Figures from company filings and market data; market data as of October 9, 2026.
, a fully integrated biopharmaceutical company, develops and commercializes therapies for central nervous system (CNS) disorders, immunology and immuno-oncology, infectious diseases, and rare diseases in the United States. The company offers TONMYA, a cyclobenzaprine HCl sublingual tablet for the treatment of fibromyalgia.
$125.20 million as of October 9, 2026.
Listed companies of a similar size in the same industry (brain and nerve treatment drugs) include Minerva Neurosciences, Inc. (NERV), Voyager Therapeutics, Inc. (VYGR), Anavex Life Sciences Corp. (AVXL), NRx Pharmaceuticals, Inc. (NRXP).